NovoCure (NVCR) Other Non-Current Assets (2014 - 2026)

NovoCure has disclosed Other Non-Current Assets across 13 years of filings, most recently posting $11.2 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $11.2 million, down 22.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (down 22.67% YoY), and the FY2025 annual result was $10.6 million, down 27.51% from the prior year.
• Other Non-Current Assets came in at $11.2 million for Q1 2026 at NovoCure, up from $10.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $15.6 million in Q2 2025 to a low of $10.6 million in Q4 2025.
• The 5-year median for Other Non-Current Assets is $12.2 million (2024), against an average of $12.6 million.
• Across the five-year window, Other Non-Current Assets soared 33.71% in 2023 and dropped 27.51% in 2025, its largest moves.
• NovoCure's Other Non-Current Assets stood at $11.2 million in 2022, then climbed by 25.63% to $14.0 million in 2023, then gained by 4.25% to $14.6 million in 2024, then slipped by 27.51% to $10.6 million in 2025, then increased by 5.7% to $11.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $11.2 million (Q1 2026), $10.6 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.